rs546381069
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4_StrongBP6
The NM_001386393.1(PANK2):c.53G>A(p.Arg18Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000793 in 1,488,860 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R18G) has been classified as Likely benign.
Frequency
Consequence
NM_001386393.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PANK2 | NM_001386393.1 | c.53G>A | p.Arg18Gln | missense_variant | 1/7 | ENST00000610179.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PANK2 | ENST00000610179.7 | c.53G>A | p.Arg18Gln | missense_variant | 1/7 | 1 | NM_001386393.1 | P2 |
Frequencies
GnomAD3 genomes ? AF: 0.000171 AC: 26AN: 152182Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000288 AC: 25AN: 86722Hom.: 0 AF XY: 0.000225 AC XY: 11AN XY: 48926
GnomAD4 exome AF: 0.0000696 AC: 93AN: 1336564Hom.: 1 Cov.: 79 AF XY: 0.0000609 AC XY: 40AN XY: 657274
GnomAD4 genome ? AF: 0.000164 AC: 25AN: 152296Hom.: 0 Cov.: 33 AF XY: 0.000188 AC XY: 14AN XY: 74468
ClinVar
Submissions by phenotype
Pigmentary pallidal degeneration Uncertain:1Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Invitae | Jan 21, 2024 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Department of Neurology, Xijing Hospital, Fourth Military Medical University | Mar 01, 2022 | - - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jul 12, 2022 | Variant summary: PANK2 c.383G>A (p.Arg128Gln) results in a conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00029 in 86722 control chromosomes (gnomAD), predominantly at a frequency of 0.0033 within the East Asian subpopulation in the gnomAD database. The observed variant frequency within East Asian control individuals in the gnomAD database is approximately 3 fold of the estimated maximal expected allele frequency for a pathogenic variant in PANK2 causing Pantothenate Kinase-Associated Neurodegeneration phenotype (0.0011), suggesting that the variant is a benign polymorphism found primarily in populations of East Asian origin. c.383G>A has been reported in the literature in individuals affected with Pantothenate Kinase-Associated Neurodegeneration (Chang_2020). The variant was also found co-occurring with another pathogenic variant in an individual with retinitis pigmentosa (CNGA1 c.179del, p.Gly60fs, Katagiri_2014), providing supporting evidence for a benign role. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. One ClinVar submitter has assessed the variant since 2014: the variant was classified as likely benign. Based on the evidence outlined above, the variant was classified as likely benign. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at